Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines

Clinical trial NCT05142540 · TERMINATED

Trial details

NCT number: NCT05142540
Sponsor: Medical University of Graz
Status: TERMINATED
Study type: OBSERVATIONAL

Anti-SARS-CoV-2 Antibody Response

Start date: 2021-12-01
Primary completion: 2022-10-04
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.